Spinal Cord Inflammation: Molecular Imaging after Thoracic Aortic Ischemia Reperfusion Injury

Hassan Albadawi1, John W Chen1, Rahmi Oklu1

  • 1From the Department of Surgery, Division of Vascular and Endovascular Surgery (H.A., J.D.M., R.P.C., M.T.W.), and Center for System Biology and Institute for Innovation in Imaging, Department of Radiology (J.W.C., Y.W., G.W., B.P.), Massachusetts General Hospital, Harvard Medical School, 70 Blossom St, Edwards 301, Boston, MA 02114; and Department of Radiology, Division of Vascular and Interventional Radiology, Mayo Clinic, Scottsdale, Ariz (R.O.).

Radiology
|August 11, 2016
PubMed

Insights

Molecular imaging targeting myeloperoxidase (MPO) effectively detects early spinal cord inflammation after thoracic aortic ischemia-reperfusion (TAR) injury in mice. This approach shows promise for tracking inflammatory damage and neuronal loss in spinal cord injury models.

Area of Science:

  • Biomedical Imaging
  • Neuroscience
  • Inflammation Research

Background:

  • Spinal cord injury (SCI) following thoracic aortic ischemia-reperfusion (TAR) involves significant inflammation.
  • Early detection of inflammation is crucial for understanding SCI pathogenesis and developing treatments.
  • Myeloperoxidase (MPO) is a key enzyme in inflammatory processes, making it a potential imaging target.

Purpose of the Study:

  • To evaluate noninvasive molecular imaging targeting MPO for early detection of inflammation in a mouse model of TAR-induced SCI.
  • To assess the correlation between MPO activity, inflammatory markers, and neuronal loss.

Main Methods:

  • Mice underwent TAR or sham surgery.
  • Molecular imaging using Magnetic Resonance (MR) and Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) with MPO-targeted sensors was performed.
  • Immunohistochemistry, flow cytometry, and enzyme-linked immunosorbent assay (ELISA) were used to quantify myeloid cells, neuronal loss, and cytokine levels (KC, IL-6).

Main Results:

  • Molecular imaging revealed increased MPO activity and sensor retention in the injured spinal cord at 6 and 24 hours post-TAR.
  • Significant myeloid cell infiltration and neuronal loss were observed, correlating inversely with MPO activity detected by imaging.
  • Elevated levels of proinflammatory cytokines keratinocyte chemoattractant (KC) and interleukin 6 (IL-6) mirrored MPO activity.

Conclusions:

  • Noninvasive molecular imaging targeting MPO can effectively identify and track early inflammatory damage in the spinal cord after TAR.
  • MPO serves as a suitable imaging biomarker for assessing spinal cord inflammation and neuronal injury in this preclinical model.
  • The findings support the potential of MPO-targeted imaging for future clinical applications in SCI.